STSG-0002

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameSTSG-0002
Drug Alias NameSTSG-0002STSG0002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionHepatitis B virus protein X inhibitors
TargetsHepatitis B virus protein X
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesStaidson(Beijing) Biopharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Sannuo Jiayi Bio-Technology Co LtdStaidson(Beijing) Biopharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A